Model
Edge
Acrivon Therapeutics Inc.
ACRV
Filing type
8-K
Filing date
Mar 1, 2026
Updated
Mar 3, 2026 ยท 2:03 AM
Copy reference
Filing
8-K
Termination of a Material Definitive Agreement